Dr Amartya Chakraborti

Dr. Chakraborti is a highly skilled pulmonologist who seamlessly bridges respiratory medicine, critical care, and sleep disorders. Within a decade of medical practice, he has mastered advanced interventions such as EBUS, thoracoscopy, and SEMS placement. A dedicated clinician and academic, he delivers patient-centric care and leads with empathy, ensuring access to state-of-the-art pulmonary diagnostics and treatments in Eastern India.

Educational Qualifications:

• MBBS – 2010
• DTCD (Diploma in Tuberculosis & Chest Diseases) – 2014
• DNB – Respiratory Medicine – 2017
• DM – Pulmonary Medicine, Sleep & Critical Care – 2023

Publications:

• Chakraborti A, Jaiswal A, Verma PK, Singhal R. A Prospective Study of Fungal Colonization and Invasive Fungal Disease in Long-Term Mechanically Ventilated Patients in a Respiratory Intensive Care Unit. Indian J Crit Care Med. 2018;22(8):597–601.
• Patanwar S, Chakraborti A, Kumar L, Vohra V, Tayal D. Serum uric acid and clinical outcome of patients with acute exacerbation of chronic obstructive pulmonary disease.
• Med J DY Patil Vidyapeeth 2020;13:658-64.
• Munjal SK, Mudavath V, Chakraborti A, Arora P, Bhall M. HIV positivity in presumptive tuberculosis cases in a tertiary respiratory care institute in New Delhi, India. Med J DY Patil Vidyapeeth 2020;13:475-9.
• Singla R, Raghu B, Gupta A, Caminero JA, Sethi P, Tayal D, Chakraborty A, Jain Y, Migliori GB. Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room. Pulmonology. 2020 Feb 29.
• Natarajan, S., Singla, R., Singla, N., Gupta, A., Caminero, J. A., Chakraborty, A., & Kumar, V.(2020). Treatment interruption patterns and adverse events among patients on bedaquiline-containing regimen under programmatic conditions in India. Pulmonology, S2531-0437(20)30213-0.
• Bhaisare S, Gupta R, Saini J, Chakraborti A, Khot S. Sleep-Disordered Breathing in Newly Diagnosed Patients of Lung Cancer. Cureus. 2022 May 23;14(5):e25230.
• Wani AR, Kumar L, Singhal R, Chakraborti A, Khot SM. Study of the spectrum of fungal isolates in the sputum of newly diagnosed pulmonary tuberculosis patients. Trop Doct.
• 2022 Jan;52(1):95-97.
• Dutt N, Shishir S, Chauhan NK, Jalandra R, Kuwal A, Garg P, Kumar D, Vishwajeet V, Chakraborti A, Deokar K, Asfahan S, Babu A, Bajad P, Gupta N, Khurana A, Garg MK.
• Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease. Cureus. 2022 Aug 7;14(8):e27759.
• Kumawat A, Chakraborti A, Kumar S, Sonigra M, Bhatnagar A, Kumar A, Chopra KK. Study of factors leading to treatment delay in new sputum-positive pulmonary tuberculosis patients and its impact on sputum conversion. Trop Doct. 2023 Apr;53(2):227-232.
• Agarwal M, Joshi M, Gupta M, Bharti N, Chakraborti A, Sonigra M. Role of blood urea nitrogen and serum albumin ratio in predicting severity of community-acquired pneumonia (CAP). Monaldi Arch Chest Dis. 2021 Dec 3;92(3).
• Jain P , Chauhan NK , Chakraborti A , et al. Programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer: Findings from a tertiary care institute in western part of India, Indian Journal of Tuberculosis,2023, ISSN 0019-5707, https://doi.org/10.1016/j.ijtb.2023.01.001.